Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate Microbot Medical Inc. before investing.

In this article, we go over a few key elements for understanding Microbot Medical Inc.’s stock price such as:

• Microbot Medical Inc.’s current stock price and volume
• Why Microbot Medical Inc.’s stock price changed recently
• Upgrades and downgrades for MBOT from analysts
• MBOT’s stock price momentum as measured by its relative strength

About Microbot Medical Inc. (MBOT)

Before we jump into Microbot Medical Inc.’s stock price, history, target price and what caused it to recently rise, let’s take a look at some background.

Microbot Medical Inc., a clinical-stage medical device company, engages in the research, design, and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space in Israel and the United States. The company offers LIBERTY, an endovascular robotic surgical system which allows physicians to conduct a catheter-based procedure from outside the catheterization laboratory, and avoid radiation exposure, physical strain, and the risk of cross contamination for use in cardiovascular, peripheral, endovascular, and neurovascular operations. It also provides NovaCross, an intellectual property and technology in the field of intraluminal revascularization devices with anchoring mechanism and integrated microcatheter. The company has a collaboration agreement with Corewell Health for the development of LIBERTY endovascular robotic system; and Emory University, in connection with autonomous robotics in endovascular procedures. Microbot Medical Inc. was founded in 2010 and is based in Hingham, Massachusetts.

Want to learn more about Microbot Medical Inc.’s stock? Click the button below to subscribe to A+ Investor and get access to everything you need to know about Microbot Medical Inc..

Microbot Medical Inc.’s Stock Price as of Market Close

As of April 24, 2025, 12:46 PM, CST, Microbot Medical Inc.’s stock price was $2.385.

Microbot Medical Inc. is up 14.66% from its previous closing price of $2.080.

During the last market session, Microbot Medical Inc.’s stock traded between $2.090 and $2.430. Currently, there are approximately 17.19 million shares outstanding for Microbot Medical Inc..

Microbot Medical Inc.’s trailing earnings per share are negative, so the stock does not have a meaningful P/E ratio. We suggest investors evaluate other financial metrics to understand its overall valuation.

Microbot Medical Inc. Stock Price History

Microbot Medical Inc.’s (MBOT) price is currently up 57.95% so far this month.

During the month of April, Microbot Medical Inc.’s stock price has reached a high of $2.640 and a low of $1.350.

Over the last year, Microbot Medical Inc. has hit prices as high as $3.380 and as low as $0.820. Year to date, Microbot Medical Inc.’s stock is up 112.95%.

Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions

What Caused Microbot Medical Inc. Stock’s Price to Rise?

Stock prices are primarily based on seller supply and buyer demand. But have you ever wondered about what other factors affect a stock's price?

When an analyst changes their opinion of a stock by upgrading or downgrading their rating, it often leads to a sudden stock price adjustment. As of April 23, 2025, there were analysts who downgraded Microbot Medical Inc.’s stock and analysts who upgraded over the last month.

Additionally, you'll want to evaluate Microbot Medical Inc.’s financial health and valuation. Investors can use AAII's Value Grade, which combines six key valuation metrics like P/E and P/S ratios for a comprehensive analysis to conduct analysis on Microbot Medical Inc.’s valuation and financial health. This approach mitigates the limitations of single-metric evaluations.

Learn how to evaluate stocks with AAII Grades and Scores with A+ Investor today.

Lastly, news and media coverage as well as recent press reports about the company or its industry may cause stock prices to fluctuate. You can check out the most recent news articles about Microbot Medical Inc. (MBOT) by visiting AAII Stock Evaluator.

Relative Price Strength of Microbot Medical Inc.

Relative price strength measures a stock's performance against the market, helping investors identify stocks that are outperforming benchmarks.

For AAII’s Momentum Grade, a weighted relative price strength is calculated. Follow this link to learn more about the Momentum Grade.

As of April 23, 2025, Microbot Medical Inc. has a weighted four-quarter relative price strength of 25.77%, which translates to a Momentum Score of 95 and is considered to be Very Strong.

Want to learn more about how Microbot Medical Inc. is graded based on AAII’s composite scores for value, growth, quality and earnings estimate revisions? Subscribe to A+ Investor today.

Microbot Medical Inc. Stock Price: Bottom Line

As of April 24, 2025, Microbot Medical Inc.’s stock price is $2.385, which is up 14.66% from its previous closing price.

AAII advises against making stock decisions based solely on price or past returns. Instead, consider a variety of metrics, fundamentals, and analytics to evaluate a stock like Microbot Medical Inc. stock prices are influenced by market supply and demand and offer just a snapshot of a company's overall health.

Subscribing to AAII's A+ Investor provides access to comprehensive analytics and insights for confident investing.